Hikma launches Ifosfamide injection
West-Ward Pharmaceuticals, wholly-owned Hikma Pharmaceuticals’s US subsidiary has launched Ifosfamide Injection, 1g/20mL vials, the generic equivalent to Ifex.
Pharmaceuticals, Biotechnology and Life Sciences
West-Ward Pharmaceuticals, wholly-owned Hikma Pharmaceuticals’s US subsidiary has launched Ifosfamide Injection, 1g/20mL vials, the generic equivalent to Ifex.
CTI BioPharma is expecting $10 million milestone in February, 2018 from Teva, related to a milestone for U.S. Food and…
TxCell got an interest-free loan from Bpifrance, a French government agency, for the preclinical development of its most advanced CAR-Treg…
The FDA has set Novartis’s Kymriah suspension injection for patients who have relapsed or refractory diffuse large B-cell lymphona (DLBCL)…
Ipsen and Exelixis on Tuesday said that their phase 3 study of study of cabozantinib in patients with advanced liver…
Midatech Pharma will conduct a study of an investigational new drug for the treatment of the fatal childhood brain cancer…
Israel’s largest drugmaker, and world’s renown generic drug’s leading producer Teva, through it’s USA outpost Teva Ltd, said that that…
Novartises division Sandoz has asked the FDA to review their Biologic License Application for biosimilar adalimumad, related to Humira, for…
INEOS Styrolution, a global styrenics supplier with a focus on styrene monomer, polystyrene, ABS Standard and styrenic specialties, will present…
Boehringer Ingelheim Pharmaceuticals has gotten an approval from the FDA, for a broadened indication of its afatinib for patients with…